Brief: CNS Pharma Expands Pipeline With In-License Of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane

CNS Pharmaceuticals

30/07/2024 12:27

July 30 (Reuters) - CNS Pharmaceuticals Inc  CNSP.O :
    * CNS PHARMACEUTICALS EXPANDS PIPELINE WITH IN-LICENSE OF
LATE
STAGE, NOVEL POTENTIAL BLOOD BRAIN BARRIER PERMEABLE ABEOTAXANE
FOR TREATMENT OF BRAIN MALIGNANCIES

Further company coverage:  CNSP.O 

 ((Reuters.Briefs@thomsonreuters.com;))